Viracta Therapeutics (formerly Sunesis) Revenue and Competitors
Estimated Revenue & Valuation
- Viracta Therapeutics (formerly Sunesis)'s estimated annual revenue is currently $5.9M per year.
- Viracta Therapeutics (formerly Sunesis)'s estimated revenue per employee is $93,492
- Viracta Therapeutics (formerly Sunesis)'s current valuation is $116.8M. (January 2022)
Employee Data
- Viracta Therapeutics (formerly Sunesis) has 63 Employees.
- Viracta Therapeutics (formerly Sunesis) grew their employee count by 29% last year.
Viracta Therapeutics (formerly Sunesis)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | President, CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | VP Finance | Reveal Email/Phone |
6 | SVP, Regulatory | Reveal Email/Phone |
7 | VP Quality Assurance | Reveal Email/Phone |
8 | SVP, Regulatory Affairs | Reveal Email/Phone |
9 | VP, Pharmaceutical Development | Reveal Email/Phone |
10 | VP, Portfolio Planning and Program Management | Reveal Email/Phone |
Viracta Therapeutics (formerly Sunesis) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Viracta Therapeutics (formerly Sunesis)?
Viracta is focused on advancing a proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr Virus, and will pursue opportunities to address other serious virus-associated disease.
keywords:N/A
N/A
Total Funding
63
Number of Employees
$5.9M
Revenue (est)
29%
Employee Growth %
$116.8M
Valuation
N/A
Accelerator
Viracta Therapeutics (formerly Sunesis) News
2022-04-13 - Viracta Therapeutics (NASDAQ:VIRX) Rating Increased to ...
Viracta Therapeutics Inc., formerly known as Sunesis Pharmaceuticals Inc., is based in SAN DIEGO. Get Viracta Therapeutics alerts: Separately,...
Other Companies in Cardiff-by-the-Sea
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.8M | 63 | 7% | N/A |
#2 | $180.4M | 423 | 12% | $40M |